133 related articles for article (PubMed ID: 14659745)
1. Crystal structure of the catalytic domain of human ADAM33.
Orth P; Reichert P; Wang W; Prosise WW; Yarosh-Tomaine T; Hammond G; Ingram RN; Xiao L; Mirza UA; Zou J; Strickland C; Taremi SS; Le HV; Madison V
J Mol Biol; 2004 Jan; 335(1):129-37. PubMed ID: 14659745
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
[TBL] [Abstract][Full Text] [Related]
3. Catalytic activity of human ADAM33.
Zou J; Zhu F; Liu J; Wang W; Zhang R; Garlisi CG; Liu YH; Wang S; Shah H; Wan Y; Umland SP
J Biol Chem; 2004 Mar; 279(11):9818-30. PubMed ID: 14676211
[TBL] [Abstract][Full Text] [Related]
4. Human ADAM33: protein maturation and localization.
Garlisi CG; Zou J; Devito KE; Tian F; Zhu FX; Liu J; Shah H; Wan Y; Motasim Billah M; Egan RW; Umland SP
Biochem Biophys Res Commun; 2003 Jan; 301(1):35-43. PubMed ID: 12535637
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the catalytic domain of human matrix metalloproteinase 10.
Bertini I; Calderone V; Fragai M; Luchinat C; Mangani S; Terni B
J Mol Biol; 2004 Feb; 336(3):707-16. PubMed ID: 15095982
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of VAP1 reveal ADAMs' MDC domain architecture and its unique C-shaped scaffold.
Takeda S; Igarashi T; Mori H; Araki S
EMBO J; 2006 Jun; 25(11):2388-96. PubMed ID: 16688218
[TBL] [Abstract][Full Text] [Related]
7. The cysteine-rich domain regulates ADAM protease function in vivo.
Smith KM; Gaultier A; Cousin H; Alfandari D; White JM; DeSimone DW
J Cell Biol; 2002 Dec; 159(5):893-902. PubMed ID: 12460986
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
Nar H; Werle K; Bauer MM; Dollinger H; Jung B
J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.
Lang R; Braun M; Sounni NE; Noel A; Frankenne F; Foidart JM; Bode W; Maskos K
J Mol Biol; 2004 Feb; 336(1):213-25. PubMed ID: 14741217
[TBL] [Abstract][Full Text] [Related]
10. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain.
Wolfsberg TG; Straight PD; Gerena RL; Huovila AP; Primakoff P; Myles DG; White JM
Dev Biol; 1995 May; 169(1):378-83. PubMed ID: 7750654
[TBL] [Abstract][Full Text] [Related]
11. Crystal structure of RVV-X: an example of evolutionary gain of specificity by ADAM proteinases.
Takeda S; Igarashi T; Mori H
FEBS Lett; 2007 Dec; 581(30):5859-64. PubMed ID: 18060879
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of novel mouse and human ADAM33s with potential metalloprotease activity.
Yoshinaka T; Nishii K; Yamada K; Sawada H; Nishiwaki E; Smith K; Yoshino K; Ishiguro H; Higashiyama S
Gene; 2002 Jan; 282(1-2):227-36. PubMed ID: 11814695
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity.
Reverter D; Maskos K; Tan F; Skidgel RA; Bode W
J Mol Biol; 2004 Apr; 338(2):257-69. PubMed ID: 15066430
[TBL] [Abstract][Full Text] [Related]
14. The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion.
Cross JB; Duca JS; Kaminski JJ; Madison VS
J Am Chem Soc; 2002 Sep; 124(37):11004-7. PubMed ID: 12224947
[TBL] [Abstract][Full Text] [Related]
15. Allosteric inhibition of the neuropeptidase neurolysin.
Hines CS; Ray K; Schmidt JJ; Xiong F; Feenstra RW; Pras-Raves M; de Moes JP; Lange JH; Melikishvili M; Fried MG; Mortenson P; Charlton M; Patel Y; Courtney SM; Kruse CG; Rodgers DW
J Biol Chem; 2014 Dec; 289(51):35605-19. PubMed ID: 25378390
[TBL] [Abstract][Full Text] [Related]
16. ADAM33 enzyme properties and substrate specificity.
Zou J; Zhang R; Zhu F; Liu J; Madison V; Umland SP
Biochemistry; 2005 Mar; 44(11):4247-56. PubMed ID: 15766253
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of catrocollastatin/VAP2B reveal a dynamic, modular architecture of ADAM/adamalysin/reprolysin family proteins.
Igarashi T; Araki S; Mori H; Takeda S
FEBS Lett; 2007 May; 581(13):2416-22. PubMed ID: 17485084
[TBL] [Abstract][Full Text] [Related]
18. Identification and preliminary characterization of mouse Adam33.
Gunn TM; Azarani A; Kim PH; Hyman RW; Davis RW; Barsh GS
BMC Genet; 2002; 3():2. PubMed ID: 11897009
[TBL] [Abstract][Full Text] [Related]
19. Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10.
Manzetti S; McCulloch DR; Herington AC; van der Spoel D
J Comput Aided Mol Des; 2003 Sep; 17(9):551-65. PubMed ID: 14713188
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme.
Maskos K; Fernandez-Catalan C; Huber R; Bourenkov GP; Bartunik H; Ellestad GA; Reddy P; Wolfson MF; Rauch CT; Castner BJ; Davis R; Clarke HR; Petersen M; Fitzner JN; Cerretti DP; March CJ; Paxton RJ; Black RA; Bode W
Proc Natl Acad Sci U S A; 1998 Mar; 95(7):3408-12. PubMed ID: 9520379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
